10 Biggest Antidepressant Drug Companies In 2017

Page 10 of 11

2. Merck & Co., Inc. (NYSE:MRK)

Annual Revenue – $39.8 billion

Merck & Co., Inc. (NYSE:MRK) is a global healthcare company that delivers innovative health solutions. With a 125-year old history, Merck & Co., Inc. (NYSE:MRK) is the manufacturer of some of the industry leading and globally known medicines. The company spent nearly 17% of its revenues on R&D activities in 2016. Remeron, developed by Merck is one of the top-selling antidepressant drugs on the market today.

Follow Merck & Co. Inc. (NYSE:MRK)

Page 10 of 11